doi: 10.1503/cmaj.101281 Summary Keywords sodium-glucose cotransporter 2 inhibitors, glucagon-like peptide-1 receptor agonists, type 2 diabetes, metformin, meta-analysis Citation Deng R, Mei K, Song T, Huang J, Wu Y, Yu P, Yan Z and Liu X (2024) First-line treatment with sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide-1 receptor agonists in type 2 diabetic population at low risk of cardiovascular disease: a meta-analysis
These medications work by mimicking natural hormones that regulate appetite and blood sugar levels, helping patients achieve significant weight reduction when combined with lifestyle modifications
Types of eating disorders include anorexia nervosa, bulimia nervosa, binge eating disorder, avoidant restrictive food intake disorder, other specified feeding and eating disorder, pica and rumination disorder
doi: 10.1016/j.neuro.2010.05.008 20 BenkiraneA.WarlopT.IvanoiuA.BaretP.WiameE.HaufroidV.et al